生命科学资讯

GSK nabs two Frontier Biotech siRNA assets in $1B deal

Wave of deals lifts large-cap biopharma stocks

US taking a closer look at China biotech subsidies

Systimmune’s iza-bren hits phase III breast cancer goals in China

Returning to pulmonary hypertension, GSK buys 35Pharma

Pierre Fabre seeks to revive US approval chances for spurned cell therapy

Commit To Buy 10x Genomics At $15, Earn 20.6% Annualized Using Options - Nasdaq

EveryOne Medicines shuts down, ending custom cure venture that banked on new FDA pathway

Biohaven reduces scope of R&D cutbacks as pipeline progresses

MindMaze seeks 'strategic alternatives,' eyes US expansion as 2 board members exit

Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug

Thermo Fisher at Raymond James Conference: Strategic Growth Insights - Investing.com

TMO (NYSE: TMO) Form 144 lists multiple vested restricted-share lots for sale - Stock Titan

WAT - Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results - ADVFN Ltd

Prolium's $50M Series A raise; COUR Pharma touts liver drug follow-up

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub - TradingView

Theravance ends R&D, lays off 50% of workers after Phase 3 fail

Financings for March 3, 2026

In the clinic for March 3, 2026

Other news to note for March 3, 2026